Research output per year
Research output per year
Search results
-
2023
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus
MASTERPLANS Consortium & BILAG-BR consortia, 29 Jul 2023, In: Clinical Proteomics. 20, 1, 17 p., 29.Research output: Contribution to journal › Article › peer-review
Open Access -
2022
Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases
Gavan, S., Bruce, I., Payne, K. & Consortium, M., 22 Aug 2022, In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.Research output: Contribution to journal › Article › peer-review
Open Access -
2021
Distinct patterns of disease activity over time in patients with active SLE revealed using latent class trajectory models
MASTERPLANS Consortium, 29 Jul 2021, In: Arthritis Research & Therapy. 23, 1, 203.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
2020
Generating Evidence to Inform Health Technology Assessment of Treatments for Systemic Lupus Erythematosus: A Systematic Review of Decision-analytic Model-based Economic Evaluations
Gavan, S., Bruce, I. & Payne, K., 28 Jul 2020, (E-pub ahead of print) In: Lupus Science and Medicine.Research output: Contribution to journal › Article › peer-review
Open Access -
The challenges in data integration – heterogeneity and complexity in clinical trials and patient registries of Systemic Lupus Erythematosus
Le Sueur, H., Bruce, I., Geifman, N. & MASTERPLANS Consortium, 24 Jun 2020, In: B M C Medical Research Methodology. 20, 1, 164.Research output: Contribution to journal › Article › peer-review
Open Access -
2019
Clinical applications of machine learning algorithms: beyond the black box
Watson, D. S., Krutzinna, J., Bruce, I. N., Griffiths, C. E., McInnes, I. B., Barnes, M. R. & Floridi, L., 2019, In: BMJ (Clinical research ed.). 364, p. l886Research output: Contribution to journal › Article › peer-review
-
Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases
Md Yusof, M. Y., Vital, E. M., McElvenny, D. M., Hensor, E. M. A., Das, S., Dass, S., Rawstron, A. C., Buch, M. H., Emery, P. & Savic, S., 2019, In: Arthritis & rheumatology (Hoboken, N.J.). 71, 11, p. 1812-1823 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
2018
Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations
Reynolds, J., Mccarthy, E., Haque, S., Ngamjanyaporn, P., Sergeant, J., Lee, E., Lee, E., Kilfeather, S. A., Parker, B. & Bruce, I., 2018, In: Arthritis Research and Therapy. 20, 173, 173.Research output: Contribution to journal › Article › peer-review
Open Access -
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
British Isles Lupus Assessment Group Biologics Register, 1 Mar 2018, In: Rheumatology. 57, 3, p. 470-479 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary
British Society for Rheumatology Standards, Audit and Guidelines Working Group & Bruce, I. N., 1 Jan 2018, In: Rheumatology (Oxford, England). 57, 1, p. 14-18 5 p.Research output: Contribution to journal › Article › peer-review
-
The Economic Case for Precision Medicine
Gavan, S., Thompson, A. & Payne, K., 2018, In: Expert Review of Precision Medicine and Drug Development.Research output: Contribution to journal › Article › peer-review
Open Access -
2017
A framework for remission in SLE: Consensus findings from a large international task force on definitions of remission in SLE (DORIS)
Van Vollenhoven, R., Voskuyl, A., Bertsias, G., Aranow, C., Aringer, M., Arnaud, L., Askanase, A., Balážová, P., Bonfa, E., Bootsma, H., Boumpas, D., Bruce, I., Cervera, R., Clarke, A., Coney, C., Costedoat-Chalumeau, N., Czirják, L., Derksen, R., Doria, A. & Dörner, T. & 30 others, , 2017, In: Annals of the rheumatic diseases. 76, 3, p. 554-561 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Can We Identify Who Gets Benefit or Harm from Mycophenolate Mofetil in Systemic Lupus Erythematosus? A Systematic Review
Mendoza-Pinto, C., Pirone, C., van der Windt, D. A. W. M., Parker, B. & Bruce, I., 2017, In: Seminars in arthritis and rheumatism.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinicians approaches to management of background therapy in Systemic Lupus Erythematosus patients in clinical remission: Results of an international observational survey
Ngamjanyaporn, P., Mccarthy, E., Sergeant, J., Reynolds, J., Skeoch, S., Parker, B. & Bruce, I., 1 Jun 2017, In: Lupus Science & Medicine. 4, 1, 8 p., e000173.Research output: Contribution to journal › Article › peer-review
Open Access -
Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): a systematic review
Pirone, C., Mendoza-Pinto, C., van der Windt, D. A. W. M., Parker, B., O'Sullivan, M. & Bruce, I., 2017, In: Seminars in arthritis and rheumatism. 47, 3, p. 384-396Research output: Contribution to journal › Article › peer-review
Open Access